Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Horm Behav ; 62(1): 43-9, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22565127

RESUMO

There is an association between hypertension and reproductive dysfunction. Angiotensin II (Ang II) is involved in the pathogenesis of hypertension and the regulation of reproduction. The present study aimed to determine whether the angiotensinergic system mediates the effects of hypertension on reproductive function in male rats subjected to a two-kidney, one-clip (2K1C) model. Sexual behavior parameters, gametogenesis and plasma concentrations of Ang II, testosterone, prolactin and corticosterone were evaluated in male rats 28days after 2K1C or sham surgery and losartan (Los) treatment (a type 1 angiotensin II (AT1) receptor antagonist) or vehicle (V) treatment. The animals were divided into Sham+V, 2K1C+V, Sham+Los and 2K1C+Los groups. The 2K1C+V group showed a hypertensive response, inhibition of sexual behavior, spermatogenesis dysfunction, and increases in plasma Ang II and prolactin. Conversely, plasma testosterone decreased, and plasma corticosterone remained constant. Losartan treatment normalized blood pressure and prevented the changes in plasma testosterone and prolactin, sexual behavior and spermatogenesis in the 2K1C+Los group. In addition, losartan treatment caused an additional increase in circulating Ang ll in both groups (Sham+Los and 2K1C+Los). Together, these results suggest that Ang ll, acting through the AT1 receptor, modulates behavioral and endocrine parameters of reproductive function during renovascular hypertension. In addition, the effects of circulating Ang II on plasma testosterone and prolactin seem to contribute to the spermatogenic and sexual dysfunctions in hypertensive rats.


Assuntos
Hipertensão Renovascular/fisiopatologia , Receptor Tipo 1 de Angiotensina/fisiologia , Espermatogênese/fisiologia , Angiotensina II/sangue , Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Animais , Corticosterona/sangue , Hipertensão Renovascular/tratamento farmacológico , Losartan/uso terapêutico , Masculino , Prolactina/sangue , Ratos , Ratos Wistar , Comportamento Sexual Animal/efeitos dos fármacos , Comportamento Sexual Animal/fisiologia , Espermatogênese/efeitos dos fármacos , Testosterona/sangue
2.
Auton Neurosci ; 132(1-2): 27-36, 2007 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-17045850

RESUMO

Several studies demonstrated the involvement of 5-hydroxytryptamine (5-HT) and its different receptor subtypes in the modulation of neurotransmission of cardiovascular reflexes in the nucleus tractus solitarii (NTS). Moreover, anatomic evidence suggests that nucleus raphe obscurus (ROb) is a source of 5-HT-containing terminals within the NTS. In the present study we investigated the possible changes in the cardiovascular responses to peripheral chemoreceptor activation by potassium cyanide (KCN, i.v.) following ROb stimulation with L-glutamate (10 nmol/50 nL) and also whether 5-HT3 receptors in the caudal commissural NTS are involved in this neuromodulation. The results showed that stimulation of the ROb with L-glutamate in awake rats (n=15) produced a significant reduction in the bradycardic response 30 s after the microinjection (-182+/-19 vs -236+/-10 bpm; Wilcoxon test) but no changes in the pressor response to peripheral chemoreceptor activation (43+/-4 vs 51+/-3 mmHg; two-way ANOVA) in relation to the control. Microinjection of 5--HT3 receptors antagonist granisetron (500 pmol/50 nL), but not the vehicle, into the caudal commissural NTS bilaterally prevented the reduction of chemoreflex bradycardia in response to microinjection of L-glutamate into ROb. These data indicate that 5-HT-containing projections from ROb to the NTS play an inhibitory neuromodulatory role in the chemoreflex evoked bradycardia by releasing 5-HT and activating 5-HT3 receptors in the caudal NTS.


Assuntos
Bradicardia/metabolismo , Células Quimiorreceptoras/metabolismo , Coração/inervação , Receptores 5-HT3 de Serotonina/metabolismo , Reflexo/fisiologia , Núcleo Solitário/metabolismo , Animais , Pressão Sanguínea/efeitos dos fármacos , Células Quimiorreceptoras/efeitos dos fármacos , Estado de Consciência , Ácido Glutâmico/administração & dosagem , Granisetron/administração & dosagem , Frequência Cardíaca/efeitos dos fármacos , Injeções Intraventriculares , Masculino , Microinjeções , Vias Neurais/metabolismo , Ratos , Ratos Wistar , Receptores 5-HT3 de Serotonina/efeitos dos fármacos , Reflexo/efeitos dos fármacos , Antagonistas da Serotonina/administração & dosagem , Núcleo Solitário/efeitos dos fármacos
3.
Fisioter. mov ; 6(1): 92-9, 1993. ilus
Artigo em Português | LILACS | ID: lil-152309

RESUMO

O presente artigo visa expor informaçöes sobre a utlizaçäo da crioterapia principalmente na fase aguda do trauma. Observou-se que, em funçäo das alteraçöes fisiológicas provocadas pela crioterapia, tais como vasoconstriçäo e diminuiçäo do metabolismo, os quais promovem reduçäo do edema e da hipóxia secundária ocorridos na lesäo primária, seus melhores resultados se fazem presentes quando esta é aplicada na fase aguda do traumatismo. Evitando, desta forma, que a lesäo se complique, favorecendo a mobilizaçäo precose e a reabilitaçäo


Assuntos
Crioterapia/estatística & dados numéricos , Ferimentos e Lesões/terapia , Crioterapia , Crioterapia/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...